← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Astrazeneca Pharmaceuticals, Lp
Wilmington, DE
$8,289,590
Total funding
2
Grants
Funding over time
peak $3M · FY2021–24$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
'24
Funding mix
By agency
NIH$8,289,590 · 2
By mechanism
UG3$5,265,428 · 1
UH3$3,024,162 · 1
Investigators at Astrazeneca Pharmaceuticals, Lp
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
A novel and highly selective orexin 1 receptor antagonist for the treatment of patients with opioid use disorder.$3,032,676
UG3 · FY2021 · DA
A novel and highly selective orexin 1 receptor antagonist for the treatment of patients with opioid use disorder.$3,024,162
UH3 · FY2024 · DA
A novel and highly selective orexin 1 receptor antagonist for the treatment of patients with opioid use disorder.$2,232,752
UG3 · FY2022 · DA